Treatment Pipeline

There are now more than 160 trials underway testing around 130 experimental treatments for Alzheimer’s across the globe, with over 40 in Phase 3. With this treatment pipeline and the first new treatment which slows cognitive decline in early-stage Alzheimer’s already available in the US, Japan and China, we are closer than ever before to have life-changing treatments available for the diseases that cause dementia. Treatments are also being developed to help manage symptoms and enhance cognition.

Estimated number of drug candidates for a single success in Alzheimer’s disease drug development compared to the average